[LXRX] QoQ Quarter Result on 31-Dec-2019 [#Q4]

Stock
[LXRX] Lexicon Pharmaceuticals, Inc.
Announcement Date
12-Mar-2020
Financial Year
2019
Quarter
31-Dec-2019 [#Q4]
Profit Trend
QoQ- -122.62%
YoY- -204.74%
Quarter Report
LXRX's Result
LXRX's Financial Summary
View:
Show?
Quarter Result
30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 CAGR
Revenue 6,634 9,163 7,999 8,727 294,448 9,682 9,216 -19.63%
PBT 82,603 -69,071 -66,611 -51,138 220,072 -23,018 -21,797 -
Tax 4,118 5,125 958 335 -6,014 -219 789 199.98%
NP 82,603 -69,071 -66,611 -51,138 226,086 -23,018 -21,797 -
Tax Rate -4.99% - - - 2.73% - - -
Total Cost -75,969 78,234 74,610 59,865 68,362 32,700 31,013 -
Ratio Analysis
30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 CAGR
NP Margin 1,245.15 -753.80 -832.74 -585.97 76.78 -237.74 -236.51 -
Per Share
30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 CAGR
EPS 0.77 -0.65 -0.63 -0.48 2.13 -0.22 -0.21 -
EPS Diluted 0.71 -0.65 -0.63 -0.48 1.95 -0.22 -0.21 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.